Details for: MINT-PIOGLITAZONE
Company: MINT PHARMACEUTICALS INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02326477 | MINT-PIOGLITAZONE | PIOGLITAZONE (PIOGLITAZONE HYDROCHLORIDE) | 15 MG | TABLET | ORAL |
| 02326485 | MINT-PIOGLITAZONE | PIOGLITAZONE (PIOGLITAZONE HYDROCHLORIDE) | 30 MG | TABLET | ORAL |
| 02326493 | MINT-PIOGLITAZONE | PIOGLITAZONE (PIOGLITAZONE HYDROCHLORIDE) | 45 MG | TABLET | ORAL |
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
Your doctor has prescribed MINT-PIOGLITAZONE to treat type 2 diabetes, as an addition to diet and exercise, in order to improve your blood sugar control. MINT-PIOGLITAZONE may be used alone or in combination with a sulfonylurea or metformin.
What it does
MINT-PIOGLITAZONE is a member of a class of drugs that are insulin-sensitizing agents. MINT-PIOGLITAZONE helps your body respond better to its own insulin, thereby reducing blood sugar levels in the body. Because MINTPIOGLITAZONE does not cause your body to produce more insulin, it rarely causes hypoglycemia (low blood sugar) when used alone. Even if you are taking MINT-PIOGLITAZONE, you should still exercise and follow the recommended nutritional plan for your diabetes.
When it should not be used
MINT-PIOGLITAZONE should not be used by patients who:
- have or have had heart problems or heart failure
- have serious liver damage
- are pregnant
- are allergic to pioglitazone hydrochloride or any other ingredients of MINT-PIOGLITAZONE
- have or have had bladder cancer
- have blood or a red colour in their urine
What the medicinal ingredient is
Pioglitazone hydrochloride
What the non-medicinal ingredients are
Carboxylmethylcellulose calcium, hydroxypropyl cellulose, lactose monohydrate and magnesium stearate.
What dosage form it comes in
MINT-PIOLIGTAZONE is available as tablets of 15 mg, 30 mg or 45 mg.
Warnings and precautions
WARNINGS AND PRECAUTIONS
Because MINT-PIOLIGTAZONE works only in the presence of insulin, it should not be used if you have type 1 diabetes (when the pancreas does not produce insulin).
Serious side effects with MINT-PIOGLITAZONE include:
- • heart failure. Symptoms of heart failure include shortness of breath, weakness, tiredness, swelling (edema), or unusual weight gain
- liver problems. Symptoms of liver problems include tiredness, lack of appetite, dark urine, yellowing of the skin or the white part of the eye
- bladder cancer. Symptoms of bladder cancer include blood or a red colour in your urine, an increased need to urinate, or pain while you urinate
MINT-PIOGLITAZONE is not approved for use with metformin and a sulfonylurea, therefore MINTPIOGLITAZONE should not be taken with metformin and a sulfonylurea.
MINT-PIOGLITAZONE is not approved for use with insulin therapy, therefore MINT-PIOGLITAZONE should not be taken with insulin.
If you are taking MINT-PIOGLITAZONE with a sulfonylurea, you may develop low blood sugar. Make sure to ask your doctor, pharmacist, or diabetes educator what to do if your blood sugar is low. Teach you friends, coworkers, and family members what they can do to help you if you have low blood sugar.
Consult your doctor promptly during periods of stress, such as fever, trauma, infection or surgery, since your medication requirements may change during these times.
Fractures, usually in the hand, upper arm or foot, have been seen with MINT-PIOGLITAZONE use in women. Talk to your doctor about the risk of fracture.
Before or while taking MINT-PIOGLITAZONE, talk to your doctor or pharmacist if you:
- have liver disease. MINT-PIOGLITAZONE is not recommended in patients with liver disease.
- are planning to become pregnant. Only insulin should be used during pregnancy to maintain blood glucose levels as close to normal as possible.
- are breastfeeding
- are a woman who has not reached menopause but have no menstrual periods. You may become pregnant unless you use an effective method of birth control. MINTPIOGLITAZONE, like other drugs in this class, may cause women with insulin resistance to ovulate again.
- have edema (water retention)
MINT-PIOGLITAZONE should not be used in children under 18 years of age.
Interactions with this medication
Drugs that interact with MINT-PIOGLITAZONE include:
Oral Contraception. Women using oral birth control pills should check with their doctor about the possible need to adjust the dose or use alternative methods of contraception when taking MINT-PIOGLITAZONE. Women should also inform their doctors of any changes in their monthly cycle.
MINT-PIOGLITAZONE may also interact with some other drugs such as gemfibrozil, rifampicin, nifedipine and atorvastatin calcium. Tell your doctor if you are taking these medicines.
Proper use of this medication
Usual Dose:
MINT-PIOGLITAZONE should be taken once daily without regard to meals. The initial dose is 15 or 30 mg once daily. Do not exceed 45 mg once daily.
Take your MINT-PIOGLITAZONE each day, as instructed by your doctor or pharmacist. MINT-PIOGLITAZONE can help you control your blood glucose levels only if you take it regularly. MINT-PIOGLITAZONE should generally be taken at the same time each day at whatever time you find most convenient to remember.
Your doctor has prescribed MINT-PIOGLITAZONE specifically for you. Do not give your medicine to anyone else, even if they have a similar condition.
Overdose:
In the event of overdosage, consult your doctor, pharmacist, or contact a poison control centre immediately.
Missed Dose
If you miss a dose of MINT-PIOGLITAZONE, do not take a double dose to make up for the missed dose. Take your dose at the regular time on the following day
Monitoring:
- Fasting blood glucose: Test your blood sugar levels with your personal glucose meter as often as your doctor recommends.
- Glycosylated hemoglobin (HbA1c): This blood test is done periodically to determine the average control of your blood sugar levels.
- Liver Enzymes: Your doctor may recommend a blood test to monitor your liver function before you start MINTPIOGLITAZONE and may repeat this test occasionally while you take MINT-PIOGLITAZONE.
- Eye: should be checked regularly. Rarely, some patients have experienced vision changes due to swelling in the back of the eye while taking MINT-PIOGLITAZONE.
Side effects and what to do about them
The following side effects have been commonly reported with MINT-PIOGLITAZONE (could affect up to 1 in 10 patients):
- Edema (fluid retention or swelling) which could lead to heart failure. If you notice swelling in extremities (arms and legs, hands and feet), unusually rapid increase in weight, tiredness, trouble breathing or shortness of breath, call your doctor. These symptoms, although not specific, may signal heart problems or heart failure.
- Low blood sugar (hypoglycemia) if you are taking MINTPIOGLITAZONE in combination with another diabetes medicine (e.g., metformin or a sulfonylurea). Dizziness, lack of energy, drowsiness, headache, trembling, sweating, or hunger may mean that your blood sugar is too low. This can happen if you skip meals, drink alcohol, use another medicine that lowers blood sugar, exercise (particularly hard or long), or if you have certain medical problems. Call your doctor if you feel that your symptoms of low blood sugar are uncomfortable. If you are using MINTPIOGLITAZONE by itself, there is less risk of having low blood sugar.
- Increased weight. Tell your doctor if you gain a lot of weight in a short period of time.
The following side effects have been reported rarely with pioglitazone hydrochloride (could affect up to 1 in 1000 patients):
- Liver problems. If you experience nausea, vomiting, stomach pain, lack of appetite, tiredness, dark urine, or yellowing of the skin, stop taking MINTPIOGLITAZONE and call your doctor right away.
- Breakthrough bleeding (unexpected vaginal bleeding or spotting) while using oral contraceptives, or generally, if you experience any symptoms that persist or become troublesome, these should be discussed with your doctor.
- Blurred vision due to swelling (or fluid) in the back of the eye.
- Fractures, usually in the hand, upper arm or foot, have been seen with MINT-PIOGLITAZONE use in women. Talk to your doctor about the risk of fracture
- Bladder cancer. If you experience blood or a red colour in your urine, an increased need to urinate, or pain while you urinate, stop taking MINT-PIOGLITAZONE and call your doctor right away.
The following side effects have been reported very rarely with MINT-PIOGLITAZONE (could affect up to 1 in 10,000 patients):
- Heart failure or pulmonary edema (fluid accumulation in the lungs). Symptoms of heart failure include shortness of breath, getting tired easily after light physical activity such as walking, waking up short of breath at night and swollen ankles or feet. Symptoms of fluid in the lungs are breathlessness, which may be very severe and usually worsens on lying down. Stop taking MINTPIOGLITAZONE and call your doctor right away if you experience these symptoms.
- Anemia (low red blood cell count) which may make you feel very weak or tired.
- Swelling of the face, lips, mouth, tongue or throat (which may cause difficulty in swallowing or breathing); hives or rash (which may be itchy). Stop taking MINTPIOGLITAZONE and call your doctor right away if you experience these symptoms.
| Symptom / effect | Talk to your healthcare professional Only if severe | Talk to your healthcare professional In all cases | Stop taking drug and get immediate medical help |
|---|---|---|---|
| Common | |||
| Fluid retention or swelling in extremities (arms and legs, hands and feet) | ✔ | ||
| Common (when taken with other antidiabetic medicines) | |||
| Low blood sugar (hypoglycemia): Dizziness, lack of energy, drowsiness, headache, trembling sweating, hunger | ✔ | ||
| Rare | |||
| Liver problems: nausea, vomiting, stomach pain, lack of appetite, tiredness, dark urine, or yellowing of the skin | ✔ | ||
| Blurred vision or decreased vision [which may be due to swelling (or fluid) in the back of the eye]. | ✔ | ||
| Fractures, usually in the hand, upper arm or foot, in women. | ✔ | ||
| Bladder cancer: blood or red colour in urine, increased need to urinate, pain while you urinate | ✔ | ||
| Very rare | |||
| Heart failure or fluid in the lungs (pulmonary edema): trouble breathing or shortness of breath, getting tired easily after light physical activity, unusual tiredness, waking up short of breath at night, swollen ankles or feet, unusually rapid increase in weight | ✔ | ||
| Allergic reactions: swelling of the face, lips, mouth, tongue or throat (may cause difficulty in swallowing or breathing), hives or rash | ✔ | ||
This is not a complete list of side effects. For any unexpected effects while taking MINT-PIOGLITAZONE, contact your doctor or pharmacist.
How to store
Store MINT-PIOGLITAZONE in its bottle with the cap tightly closed at room temperature (15°-30°C). Protect from moisture.
Keep out of the reach and sight of children.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugshealth-products/medeffect-canada/adverse-reactionreporting.html) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
MORE INFORMATION
If you want more information about MINT-PIOGLITAZONE:
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website: (https://health-products.canada.ca/dpdbdpp/index-eng.jsp); the manufacturer’s website www.mintpharmaceuticals.com, or by calling 1-877- 398-9696.
This leaflet was prepared by Mint Pharmaceuticals Inc., in Mississauga, Ontario.
Last revised: February 18, 2021